Porträt Christa Müller

Christa Müller

Christa E. Müller studied pharmacy at the University of Tübingen, Germany, and received her Ph.D. in Pharmaceutical/Medicinal Chemistry from the same university. After postdoctoral stays with John W. Daly in the Laboratory of Bioorganic Chemistry at the National Institutes of Health in Bethesda, Maryland, USA (1989-1990 and 1992), she became Associate Professor of Pharmaceutical Chemistry at Würzburg University in Germany. Since 1998 she is Full Professor of Pharmaceutical & Medicinal Chemistry at Bonn University and a founder of the Pharma-Center Bonn and the Bonn International Graduate School of Drug Sciences (BIGS DrugS). Her scientific interests are focused on the medicinal chemistry, structural biology, and molecular pharmacology of purine-binding membrane proteins (purine receptors, ectonucleotidases), orphan G protein-coupled receptors and G proteins, and recently also on coronavirus therapeutics. Disease indications include neurodegenerative and inflammatory diseases, cancer, and infections. She has published more than 500 scientific papers and patents in the field of medicinal chemistry and pharmacology. Among a number of awards, she received the Nauta Pharmacochemistry Award for Medicinal Chemistry and Chemical Biology by the European Federation of Medicinal Chemistry (EFMC) in 2018, the Tony Holý Lecture Award by the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, in 2019, and she was the first recipient of the Dieter Binder Lectureship in Medicinal Chemistry by the Society of Austrian Chemists (awarded in 2022). Since 2021, she acts as Editor-in-Chief of ACS Pharmacology & Translational Science.